Dietary Melatonin and Glycine Decrease Tumor Growth through Antiangiogenic Activity in Experimental Colorectal Liver Metastasis

Dietary Melatonin and Glycine Decrease Tumor Growth through Antiangiogenic Activity in Experimental Colorectal Liver Metastasis

Despite multimodal treatment strategies, clinical outcomes of advanced stage colorectal cancer (CRC) patients remain poor. Neoadjuvant/adjuvant chemotherapy efficacy is limited due to chemoresistance, toxicity, and negative side effects. Since both melatonin and glycine have anti-cancer activities w...

Full description

Bibliographic Details
Main Authors: Mindaugas Kvietkauskas, Viktorija Zitkute, Bettina Leber, Kestutis Strupas, Philipp Stiegler, Peter Schemmer
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Nutrients
Subjects:
melatonin
glycine
colorectal cancer
liver metastases
anticancer drug combination
Online Access:https://www.mdpi.com/2072-6643/13/6/2035

Internet

https://www.mdpi.com/2072-6643/13/6/2035

Similar Items